Benchmarking
-
Technology & Infrastructure · Models & LLMs Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
Insider Brief PRESS RELEASE — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of the Open Drug Discovery and Development Consortium (O3DC) – www.o3dc.org, an open… -
Technology & Infrastructure · Models & LLMs Large Language Models Take on Reproductive Health Predictions, Surpass Human Benchmarks in Key Cases
-
Technology & Infrastructure · Applications & agents IBM Research Introduces ITBench to Evaluate AI-Powered IT Automation
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.